The sums committed and what they produced.
The Institute conducts none of this work itself. It funds it, in collaboration with the CHUM Research Centre, and publishes what each project cost.
The amounts below are those committed by the Institute. They are not the total budget of the projects, which also receive public and institutional funding.
close to $165,000
After an apparently effective chemotherapy, some ovarian cells do not die: they go dormant, then start again. Francis Rodier identified the phenomenon and how to attack it. Published in Nature Communications, the work led to a clinical trial.
Francis Rodier, Anne-Marie Mes-Masson, Diane Provencher
close to $1,000,000
Tumours contain immune cells able to fight them, but dormant. They are collected, woken and multiplied into the billions in a CHUM laboratory, then returned to the patient.
Simon Turcotte, Rahima Jamal, Réjean Lapointe, Jean-François Cailhier, John Stagg
more than $382,000
The bacteria in our gut shape how we respond to treatment. Dr Routy showed that a course of antibiotics can neutralise an immunotherapy. A lung cancer tissue bank alone received more than $300,000.
Bertrand Routy, Manuela Santos, Réjean Lapointe
more than $54,000
An alliance with Polytechnique Montréal around a simple idea: fit a laboratory onto a slide, to observe a treatment's effect on a patient's sample before giving it to them.
Thomas Gervais, Anne-Marie Mes-Masson, Dominique Trudel, Francis Rodier, Marie-Claude Bourgeois-Daigneault
For more than thirty years, the teams of these two pioneers have reshaped how prostate and ovarian cancers are managed.
Fred Saad, Diane Provencher
A team from the Research Centre submits its project.
The Institute's expert committee assesses its scientific value.
Funding is granted, with its amount and duration.
Results appear in peer reviewed journals.
This work comes out of more than twenty years of banking samples from women with ovarian cancer. Without them, none of it would exist.
